Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UBS Analyst Upgrades Price Target for Hess Midstream to 38

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
MMM stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

UBS analyst Brian Reynolds is bullish on Hess Midstream (NYSE:HESM), maintaining a Buy rating and increasing the price target to $38, up from $35. This adjustment signifies a strong belief in the company’s future performance. Previously, UBS had a Buy rating but had lowered the price target to $36. The current forecast suggests an average 12-month price target of $36.33 for Hess Midstream Partners, indicating a potential upside of 4.83% according to analysts’ projections.

HESM Stock Shows Strong Performance on March 2, 2024: Potential for Continued Growth

On March 2, 2024, HESM stock had a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time and may have strong potential for continued growth.

The price of HESM shares increased by $0.55 since the market last closed, representing a 1.61% rise. This is a positive sign for investors, as it shows that the stock is gaining value. However, it is important to note that the stock closed at $34.64, which means that it is still relatively affordable for investors looking to buy in.

Overall, HESM stock had a strong performance on March 2, 2024, with a price increase during regular trading hours. Investors should continue to monitor the stock’s performance and consider factors such as market trends, company news, and financial reports when making investment decisions.

HESM Stock Performance Analysis: Promising Results and Growth Potential for Investors

On March 2, 2024, HESM stock performance showed promising results based on the financial data provided by CNN Money. The company reported a total revenue of $1.35 billion for the past year, with a slight increase of 5.76% compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $356.50 million.

Net income for HESM was reported at $118.60 million for the past year, showing a significant increase of 41.36% compared to the previous year. Similar to the total revenue, the net income also remained flat since the last quarter, with a reported figure of $37.50 million.

Earnings per share (EPS) for HESM stood at $2.11 for the past year, reflecting a modest increase of 3.95% compared to the previous year. The EPS remained unchanged since the last quarter, at $0.55.

Overall, HESM’s financial performance indicates a positive trend with increasing net income and earnings per share. The company’s ability to maintain steady revenue growth despite fluctuations in the market is a good sign for investors. However, the flat performance since the last quarter may raise some concerns about the company’s future growth prospects.

Investors and analysts will be closely monitoring HESM’s performance in the coming quarters to see if the company can sustain its growth momentum and continue to deliver strong financial results. With a solid track record of increasing net income and earnings per share, HESM remains a stock to watch in the market.

Tags: HESM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
OHI stock news

UBS Analyst Maintains Neutral Rating on Main Street Capital with Increased Price Target

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Analyst Reaffirms Neutral Rating on PayPal Holdings with Increased Price Target

Finance_Commercial (2)

Analysts Provide Mixed Ratings for NetApp Following Strong Q3 Earnings

Recommended

Coherent Stock

Coherent Shares Tumble Despite Record Earnings as Guidance Disappoints

1 month ago
Genesco Stock

Genesco Shares Tumble Despite Strong Quarterly Performance

3 weeks ago
Finance_Investment (2)

Analyst at Cantor Fitzgerald Reiterates Neutral Rating and 128 Price Target for Sarepta Therapeutics NASDAQ SRPT

2 years ago
MMM stock news

The Power of Compounded Returns A Case Study of Union Pacific Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Take-Two’s Strategic Moves Signal Confidence Ahead of Major Game Launch

Los Angeles-Based Lender Defies Industry Headwinds with Strong Dividend and Earnings

Institutional Investors Make Major Moves on Bristow Group

Is There Any Hope Left for Maravai LifeSciences Investors?

G-III Apparel Shares Face Significant Headwinds Following Disappointing Earnings

Nokia Finalizes Landmark $2.3 Billion Acquisition of Infinera

Trending

Stepan Stock
Analysis

Stepan Shares Face Market Pressure Despite Solid Operational Performance

by Robert Sasse
September 22, 2025
0

While Stepan Company delivered fundamentally sound operational results in its most recent quarter, its stock finds itself...

Paragon 28 Stock

Zimmer Biomet’s Billion-Dollar Acquisition Reshapes Orthopedic Landscape

September 22, 2025
MP Materials Stock

MP Materials Stock Surges Following Key Index Inclusion and Major Partnerships

September 22, 2025
Take-Two Stock

Take-Two’s Strategic Moves Signal Confidence Ahead of Major Game Launch

September 22, 2025
Preferred Bank of Los Angeles Stock

Los Angeles-Based Lender Defies Industry Headwinds with Strong Dividend and Earnings

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Stepan Shares Face Market Pressure Despite Solid Operational Performance
  • Zimmer Biomet’s Billion-Dollar Acquisition Reshapes Orthopedic Landscape
  • MP Materials Stock Surges Following Key Index Inclusion and Major Partnerships

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com